Ath

(redirected from atherosclerosis)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
AcronymDefinition
Athathlete
AthAll Time High
AthAtherosclerosis
AthAbove the Horizon
AthAround the Horn (ESPN show)
AthAluminum Trihydrate
AthA Toda Hora (Spanish: At All Times; Puerto Rico automatic teller machine)
AthAssociate of Theology (various schools)
AthAttention Hangup
AthAuthorization to Hire
AthAmerican Trading House (Newark, NJ)
AthAsk the Headhunter (est. 1995)
AthAdenotonsillar Hypertrophy
AthAir Transportable Hospital
AthAthwartship
AthAcceleration Time History
AthAbdominal Total Hysterectomy (surgery)
AthAvian Thymic Hormone
AthArmchair Treasure Hunt (UK)
AthAbsolute Threshold of Hearing
AthAutomatic THrottle
AthAttention Hang-Up
AthAndrews Travel House (UK)
AthAssign Thresholds (US DoD)
AthArtificial Time History
AthAsia Timber House (Malaysia)
AthAir Transat Holidays
AthAddicted to Hardstyle
AthAbbreviated Trouble History
AthAthens, Greece - Hellinikon (Airport Code)
AthArts Theme House (Duke University; Durham, NC)
AthApplications Techniques Hydrauliques (French hydraulics company)
AthArmored Trooper Heavy (Votoms)
AthAir Touraine Hélicoptère (French helicopter transportation company)
AthAUTODIN Transitional Hub
AthAlgorithm Test Harness
AthAxially Tilted Hyperbola (antenna)
AthAnders Tang Humor
References in periodicals archive ?
Rising focus on identification of new drug targets for atherosclerosis
The researchers emphasise, in conclusion, "Oral infections were an independent risk factor for subclinical atherosclerosis, and their association with cardiovascular risk factors persevered through the entire follow-up.
The investigators found also that, in contrast with CIMT, cardiac computed tomography (CT) measures of atherosclerosis did not differ significantly between the estradiol and placebo groups, regardless of age.
'What we found was that patients with unexplained atherosclerosis had significantly higher blood levels of these toxic metabolites that are produced by the intestinal bacteria,' said David Spence, Professor at Western University, London, Canada.
Sample size was based on the study by Sinha et al24, the plaque of atherosclerosis in GCSF and control groups (S1=0.005,S2=0.014,u1=0.058, u2=0.039), n=6, for each group, as following:
Carotid intima-media thickness is defined as the distance between the luminal–endothelial interface and the junction between the media and the adventitia on a longitudinal ultrasound image of each artery.[sup][4],[8] As a surrogate marker of atherosclerosis, intima-media thickness levels greater than 0.9 mm were associated with atherosclerosis.
In the present study, heart specimens of 600 consecutive post-mortem cases, received in die pathology section of the JLN Medical College, Ajmer, were examined grossly and microscopically for the presence and extent of atherosclerosis and evidence of myocardial infarction (MI).
Smooth Muscle Cells Contributing to Atherosclerosis. The relationship between SMCs and atherosclerosis has considerably drawn attention since Ross et al.
The concept of atherosclerosis as an inflammatory disease is based on the evidence that inflammatory cells are abundant in atherosclerotic lesions, which are the major source of cytokine that was involved in all stages of atherosclerosis and have a profound impact on the pathogenesis of this disease [9].
Purpose: Herein, the effect of artesunate, a derivant from artemisinin from the traditional Chinese herb sweet wormwood, could attenuate the progression of atherosclerosis lesion formation alone or combined with rosuvastatin in Western-type diet (WD) fed [ApoE.sup.-/-] mice, and explored its possible mechanisms.
The study of 8,020 adult Korean men without carotid atherosclerosis at baseline showed that men with persistent NAFLD had a 13% greater risk of subclinical carotid atherosclerosis, compared with those without NAFLD, after adjustment for age, smoking, alcohol, body mass index, and weight change (95% confidence interval, 1.131.35; P less than .001).
The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Full browser ?